Search

everythinglearnresearchcommunity

for

Search:↓

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Skin diseases are very common in poor areas, and there's a need for affordable ways to manage and improve skin health.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.